MedTrace Logo

Risk Factor Control Before Orthopedic Surgery

NCT01837069 · Status: TERMINATED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 198

Last updated 2020-07-27

Study results available
· View outcomes & findings →

Summary

This trial is designed to determine the best preoperative management strategy for patients undergoing orthopedic surgery.

Conditions

Interventions

DRUG

Metoprolol

25mg PO BID if the HR is elevated at preadmission testing

DRUG

Lisinopril

2.5mg PO QD if the HR is elevated at preadmission testing

DRUG

Atorvastatin

80mg PO QD at preadmission testing

BEHAVIORAL

Lifestyle counseling

Diet, exercise, medication adherance and smoking counseling

Sponsors & Collaborators

Principal Investigators

  • Jeffrey Berger, MD · NYU School of Medicine

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
21 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-02-28
Primary Completion
2018-04-02
Completion
2018-04-02
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Drugs
Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01837069 on ClinicalTrials.gov